Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Synaptic Mechanisms of Continuous Theta Burst Stimulation in Depression
NCT07560878Phase 1Recruiting
- Sponsor
- McLean Hospital
- Start
- Mar 2026
- Primary completion
- Dec 2030
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in major depressive disorder (MDD) (6 arms), sponsored by McLean Hospital. Primary endpoints: Change in P30 TMS-Evoked Potential Peak Amplitude, Change in N45 TMS-Evoked Potential Peak Amplitude and 1 more. Started Mar 2026; status: recruiting.
02
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT07560878.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07560878.